Detailansicht

Wissensnetz

Person

Christoph Eisenbach

Arzt

Name	Christoph Eisenbach
Ort	Heidelberg (Wirkungsort) Weinheim (5/2015-) (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Beziehung	Klinikum Heidelberg Universität Heidelberg. Medizinische Fakultät (außerplanmäßiger Professor) (2/2013-)
Weitere Angaben	Oberarzt der Medizinischen Klinik IV: Gastroenterologie, Infektionskrankheiten und Vergiftungen, Universitätsklinikum Heidelberg
Datensatztyp	Person
GND-Nummer	1022807560
Datensatz-ID	1022807560
Beteiligt an alle anzeigen Outcomes and costs of treating hepatitis C patients in the era of first generation protease inhibitors – results from the PAN study Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort Microscopic (collagenous) colitis in a patient with a heart transplant Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort Pharmacologic cholinesterase inhibition improves survival in acetaminophen-induced acute liver failure in the mouse Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Christoph Eisenbach

Outcomes and costs of treating hepatitis C patients in the era of first generation protease inhibitors – results from the PAN study

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Microscopic (collagenous) colitis in a patient with a heart transplant

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort

Pharmacologic cholinesterase inhibition improves survival in acetaminophen-induced acute liver failure in the mouse

Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report